Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6526
Melissa Martínez Nieto, Luis Antonio González Gómez, Juan Carlos Gómez Mireles, Sarah Monserrat Lomelí Martínez
Myeloid sarcoma (MS) is a rare neoplasm characterized by the proliferation of immature myeloid precursor cells outside the bone marrow. The pathogenesis of MS is complex and not completely understood. Moreover, it develops in any extramedullary site of the body. In this editorial, we discuss the article published by Li et al, which presents a clinical case involving a 32-year-old man who exhibited gingival inflammation in the maxillary region. It was initially diagnosed as periodontal disease. However, clinical evaluation revealed a firm, grayish-white mass which underscored the need for comprehensive diagnostics to distinguish MS from other oral conditions. This article emphasizes the different clinical presentations of similar case studies in the literature, and highlights the difficulty in diagnosing oral MS due to its rarity and variability in clinical manifestation. The treatment of MS depends on the clinical presentation, tumor location, and the patient's response to conventional therapies. The various therapeutic options currently available are analyzed and discussed. Early intervention and multidisciplinary management are crucial for improving treatment outcomes. Increased awareness and education about the various clinical presentations of MS lead to earlier diagnosis and timely treatment, thereby enhancing patients' survival and quality of life. Continued research is essential for optimizing therapeutic strategies and addressing the challenges presented by this rare neoplasm.
髓样肉瘤(MS)是一种罕见的肿瘤,其特征是骨髓外未成熟的髓样前体细胞增殖。髓系肉瘤的发病机制复杂,尚未完全明了。此外,它可在人体任何髓外部位发病。在这篇社论中,我们讨论了 Li 等人发表的一篇文章,该文章介绍了一例临床病例,患者是一名 32 岁的男性,上颌区域出现牙龈炎症。最初诊断为牙周病。然而,临床评估发现了一个坚硬的灰白色肿块,这凸显了全面诊断的必要性,以便将多发性硬化症与其他口腔疾病区分开来。本文强调了文献中类似病例研究的不同临床表现,并强调了口腔多发性硬化症的罕见性和临床表现的多变性给诊断带来的困难。口腔多发性硬化症的治疗取决于临床表现、肿瘤位置以及患者对常规疗法的反应。本文对目前可用的各种治疗方案进行了分析和讨论。早期干预和多学科管理对提高治疗效果至关重要。加强对多发性硬化症各种临床表现的认识和教育,有助于早期诊断和及时治疗,从而提高患者的生存率和生活质量。持续的研究对于优化治疗策略和应对这种罕见肿瘤带来的挑战至关重要。
{"title":"Diagnostic and therapeutic challenges of myeloid sarcoma in the oral cavity.","authors":"Melissa Martínez Nieto, Luis Antonio González Gómez, Juan Carlos Gómez Mireles, Sarah Monserrat Lomelí Martínez","doi":"10.12998/wjcc.v12.i32.6526","DOIUrl":"10.12998/wjcc.v12.i32.6526","url":null,"abstract":"<p><p>Myeloid sarcoma (MS) is a rare neoplasm characterized by the proliferation of immature myeloid precursor cells outside the bone marrow. The pathogenesis of MS is complex and not completely understood. Moreover, it develops in any extramedullary site of the body. In this editorial, we discuss the article published by Li <i>et al</i>, which presents a clinical case involving a 32-year-old man who exhibited gingival inflammation in the maxillary region. It was initially diagnosed as periodontal disease. However, clinical evaluation revealed a firm, grayish-white mass which underscored the need for comprehensive diagnostics to distinguish MS from other oral conditions. This article emphasizes the different clinical presentations of similar case studies in the literature, and highlights the difficulty in diagnosing oral MS due to its rarity and variability in clinical manifestation. The treatment of MS depends on the clinical presentation, tumor location, and the patient's response to conventional therapies. The various therapeutic options currently available are analyzed and discussed. Early intervention and multidisciplinary management are crucial for improving treatment outcomes. Increased awareness and education about the various clinical presentations of MS lead to earlier diagnosis and timely treatment, thereby enhancing patients' survival and quality of life. Continued research is essential for optimizing therapeutic strategies and addressing the challenges presented by this rare neoplasm.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6526-6533"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6534
Qiong-Yue Cao, Zheng Li
In this editorial, we comment on a recent article which addressed the therapeutic effect of aspirin plus edaravone in patients with cerebral infarction (CI). Herein, we outline the progress in therapy of CI. Apart from thrombolysis, aspirin is the most effective treatment for CI. Edaravone, a free radical scavenger, reduces endothelial cell damage and delays neuronal cell death. Aspirin plus edaravone mitigates damage to brain tissue by different mechanisms, thereby expediting the reinstation of neurological function. However, the nephrotoxic effect of edaravone, along with gastrointestinal bleeding associated with aspirin, may restrict this combination therapy. Although clinical studies have demonstrated the efficacy of thrombolytic therapy and mechanical thrombectomy, patients receiving these treatments experience modest efficacy and many adverse events. Moreover, interest in exploring natural medicines for CI is increasing, and they appear to have a high potential to protect against CI. The evolution of therapeutic strategies is expected to improve clinical outcomes of patients with CI.
在这篇社论中,我们对最近一篇探讨阿司匹林加依达拉奉对脑梗塞(CI)患者治疗效果的文章进行了评论。在此,我们概述了 CI 治疗的进展。除溶栓治疗外,阿司匹林是治疗 CI 最有效的药物。依达拉奉是一种自由基清除剂,可减少内皮细胞损伤,延缓神经细胞死亡。阿司匹林加依达拉奉可通过不同机制减轻对脑组织的损伤,从而加快神经功能的恢复。然而,依达拉奉的肾毒性作用以及阿司匹林引起的胃肠道出血可能会限制这种联合疗法。尽管临床研究已证明溶栓疗法和机械性血栓切除术具有疗效,但接受这些治疗的患者疗效一般,且不良反应较多。此外,人们对探索治疗 CI 的天然药物的兴趣日益浓厚,这些药物似乎具有很高的预防 CI 的潜力。治疗策略的发展有望改善 CI 患者的临床疗效。
{"title":"Evolving of treatment options for cerebral infarction.","authors":"Qiong-Yue Cao, Zheng Li","doi":"10.12998/wjcc.v12.i32.6534","DOIUrl":"10.12998/wjcc.v12.i32.6534","url":null,"abstract":"<p><p>In this editorial, we comment on a recent article which addressed the therapeutic effect of aspirin plus edaravone in patients with cerebral infarction (CI). Herein, we outline the progress in therapy of CI. Apart from thrombolysis, aspirin is the most effective treatment for CI. Edaravone, a free radical scavenger, reduces endothelial cell damage and delays neuronal cell death. Aspirin plus edaravone mitigates damage to brain tissue by different mechanisms, thereby expediting the reinstation of neurological function. However, the nephrotoxic effect of edaravone, along with gastrointestinal bleeding associated with aspirin, may restrict this combination therapy. Although clinical studies have demonstrated the efficacy of thrombolytic therapy and mechanical thrombectomy, patients receiving these treatments experience modest efficacy and many adverse events. Moreover, interest in exploring natural medicines for CI is increasing, and they appear to have a high potential to protect against CI. The evolution of therapeutic strategies is expected to improve clinical outcomes of patients with CI.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6534-6537"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6563
Jin Meng, Li-Mei Zhang, Zhi-Gang Wang, Xiu Zhao, Hai-Xia Bai, Ying Wang, De-Yu Chen, De-Long Liu, Cheng-Chun Ji, Yuan Liu, Lei Wang, Bo-Yang Li, Zhi-Tao Yin
Gastroduodenal tuberculosis (GD-TB) is exceptionally rare. The clinical manifestations of gastrointestinal TB are diverse and non-specific, which makes diagnosis difficult, leading to delayed diagnosis and high mortality. As a peer-reviewer of World Journal of Clinical Cases, I would like to share my opinion on the article published by this journal. The patient had no family history of TB or contact with people with TB. Primary GD-TB presenting as gastric outlet obstruction and normal findings of thoracic computed tomography increased the difficulty of diagnosis and treatment in this patient. The diagnosis and treatment scheme of this typical case have reference value for the clinical treatment of GD-TB.
{"title":"Revisiting tuberculosis as a cause of gastric outlet obstruction: Insights from a case report.","authors":"Jin Meng, Li-Mei Zhang, Zhi-Gang Wang, Xiu Zhao, Hai-Xia Bai, Ying Wang, De-Yu Chen, De-Long Liu, Cheng-Chun Ji, Yuan Liu, Lei Wang, Bo-Yang Li, Zhi-Tao Yin","doi":"10.12998/wjcc.v12.i32.6563","DOIUrl":"10.12998/wjcc.v12.i32.6563","url":null,"abstract":"<p><p>Gastroduodenal tuberculosis (GD-TB) is exceptionally rare. The clinical manifestations of gastrointestinal TB are diverse and non-specific, which makes diagnosis difficult, leading to delayed diagnosis and high mortality. As a peer-reviewer of <i>World Journal of Clinical Cases</i>, I would like to share my opinion on the article published by this journal. The patient had no family history of TB or contact with people with TB. Primary GD-TB presenting as gastric outlet obstruction and normal findings of thoracic computed tomography increased the difficulty of diagnosis and treatment in this patient. The diagnosis and treatment scheme of this typical case have reference value for the clinical treatment of GD-TB.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6563-6565"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6559
Pradeep Kumar Yadalam, Raghavendra Vamsi Anegundi, Mario Alberto Alarcón-Sánchez, Artak Heboyan
Meta-learning of dental X-rays is a machine learning technique that can be used to train models to perform new tasks quickly and with minimal input. Instead of just memorizing a task, this is accomplished through teaching a model how to learn. Algorithms for meta-learning are typically trained on a collection of training problems, each of which has a limited number of labelled instances. Multiple X-ray classification tasks, including the detection of pneumonia, coronavirus disease 2019, and other disorders, have demonstrated the effectiveness of meta-learning. Meta-learning has the benefit of allowing models to be trained on dental X-ray datasets that are too few for more conventional machine learning methods. Due to the high cost and lengthy collection process associated with dental imaging datasets, this is significant for dental X-ray classification jobs. The ability to train models that are more resistant to fresh input is another benefit of meta-learning.
牙科 X 射线元学习是一种机器学习技术,可用于训练模型,使其能够以最少的输入快速执行新任务。它不是简单地记忆任务,而是通过教授模型如何学习来实现。元学习算法通常是在一系列训练问题上进行训练,每个问题都有数量有限的标记实例。多种 X 射线分类任务,包括肺炎、2019 年冠状病毒疾病和其他疾病的检测,都证明了元学习的有效性。元学习的好处是可以在牙科 X 射线数据集上训练模型,而对于更传统的机器学习方法来说,这些数据集太少了。由于牙科成像数据集成本高、收集过程长,这对牙科 X 射线分类工作意义重大。元学习的另一个好处是能够训练出更耐受新输入的模型。
{"title":"Classification and detection of dental images using meta-learning.","authors":"Pradeep Kumar Yadalam, Raghavendra Vamsi Anegundi, Mario Alberto Alarcón-Sánchez, Artak Heboyan","doi":"10.12998/wjcc.v12.i32.6559","DOIUrl":"10.12998/wjcc.v12.i32.6559","url":null,"abstract":"<p><p>Meta-learning of dental X-rays is a machine learning technique that can be used to train models to perform new tasks quickly and with minimal input. Instead of just memorizing a task, this is accomplished through teaching a model how to learn. Algorithms for meta-learning are typically trained on a collection of training problems, each of which has a limited number of labelled instances. Multiple X-ray classification tasks, including the detection of pneumonia, coronavirus disease 2019, and other disorders, have demonstrated the effectiveness of meta-learning. Meta-learning has the benefit of allowing models to be trained on dental X-ray datasets that are too few for more conventional machine learning methods. Due to the high cost and lengthy collection process associated with dental imaging datasets, this is significant for dental X-ray classification jobs. The ability to train models that are more resistant to fresh input is another benefit of meta-learning.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6559-6562"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6538
Basma M E Mohamed, Mohamed E A Abdelrahim
In this editorial, we comment on the article by Lei et al, with a specific focus on the timing of the initiation of the antifibrotic agent pirfenidone (PFD) in the management of idiopathic pulmonary fibrosis (IPF) and its impact on lung function of IPF patients. PFD is an antifibrotic agent that is widely used in the management of IPF in both early and advanced stages. It inhibits various pathways and has antifibrotic, anti-inflammatory, and antioxidant properties. Despite dosage lowering, PFD slowed IPF progression and maintained functional capacity. The 6-min walk distance test indicated that patients tolerated adverse events well, and PFD significantly reduced the incidence of progression episodes and death. Even when a single disease-progression event occurred, continuing PFD treatment had benefits.
{"title":"Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression.","authors":"Basma M E Mohamed, Mohamed E A Abdelrahim","doi":"10.12998/wjcc.v12.i32.6538","DOIUrl":"10.12998/wjcc.v12.i32.6538","url":null,"abstract":"<p><p>In this editorial, we comment on the article by Lei <i>et al,</i> with a specific focus on the timing of the initiation of the antifibrotic agent pirfenidone (PFD) in the management of idiopathic pulmonary fibrosis (IPF) and its impact on lung function of IPF patients. PFD is an antifibrotic agent that is widely used in the management of IPF in both early and advanced stages. It inhibits various pathways and has antifibrotic, anti-inflammatory, and antioxidant properties. Despite dosage lowering, PFD slowed IPF progression and maintained functional capacity. The 6-min walk distance test indicated that patients tolerated adverse events well, and PFD significantly reduced the incidence of progression episodes and death. Even when a single disease-progression event occurred, continuing PFD treatment had benefits.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6538-6542"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6543
Ruo-Bing Qi, Zheng-Hao Wu
In this editorial we comment on the article by Ji et al. We focus specifically on the EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment and the development of drug resistance to EGFR-TKIs.
在这篇社论中,我们对 Ji 等人的文章进行了评论。我们特别关注表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)的治疗以及 EGFR-TKIs 耐药性的发展。
{"title":"Advanced lung adenocarcinoma with <i>EGFR</i> 19-del mutation transforms into squamous cell carcinoma after <i>EGFR</i> tyrosine kinase inhibitor treatment.","authors":"Ruo-Bing Qi, Zheng-Hao Wu","doi":"10.12998/wjcc.v12.i32.6543","DOIUrl":"10.12998/wjcc.v12.i32.6543","url":null,"abstract":"<p><p>In this editorial we comment on the article by Ji <i>et al</i>. We focus specifically on the EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment and the development of drug resistance to EGFR-TKIs.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6543-6546"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6566
Anju Gupta, Brinda Valecha, Nishkarsh Gupta
The authors have conducted a comprehensive investigation into the safety and effectiveness of butorphanol for epidural analgesia during labor. Their critical analysis of the paper and discussion of the technique's advantages and disadvantages provide a thorough understanding of the topic.
{"title":"Butorphanol in epidural: Could this be the breakthrough solution for safe and effective labor analgesia that we've been waiting for?","authors":"Anju Gupta, Brinda Valecha, Nishkarsh Gupta","doi":"10.12998/wjcc.v12.i32.6566","DOIUrl":"10.12998/wjcc.v12.i32.6566","url":null,"abstract":"<p><p>The authors have conducted a comprehensive investigation into the safety and effectiveness of butorphanol for epidural analgesia during labor. Their critical analysis of the paper and discussion of the technique's advantages and disadvantages provide a thorough understanding of the topic.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6566-6569"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6517
Yumna Shahid, Muhammad Aarish Anis, Shahab Abid
The worldwide burden of tuberculosis (TB) has increased and it can involve virtually any organ of the body. Intestinal TB accounts for about 2% of the cases of TB worldwide. The ileocecal region is the most commonly affected site, and the foregut is rarely involved. The reported incidence is approximately 0.5%. Esophageal TB presents with dysphagia, weight loss, and hematemesis in rare cases. Gastroduodenal TB usually manifests with symptoms such as nausea, vomiting, weight loss, and sometimes with gastric outlet obstruction. Gastroscopy may reveal shallow ulcers in stomach and duodenal deformity when underlying TB is suspected, therefore histopathology plays pivotal role. On computed tomography, duodenal TB typically manifests as duodenal strictures predominantly, accompanied by extrinsic compression, and occasionally as intraluminal mass. But their diagnosis can easily be missed if proper biopsies are not taken and samples are not sent for GeneXpert testing, TB polymerase chain reaction investigation and histopathological analysis. Despite being in close proximity to the lungs, the esophagus and stomach are rare sites of TB. The reasons could be low gastric pH and acidity which does not let mycobacterium grow. But there are various case reports of TB involving the foregut. We have summarized the rare cases of foregut TB in different sections and highlighted the importance of esophagogastroduodenoscopy, histopathology and advanced techniques like endoscopic ultrasound in establishing the diagnosis.
{"title":"Foregut tuberculosis: Too close but miles apart.","authors":"Yumna Shahid, Muhammad Aarish Anis, Shahab Abid","doi":"10.12998/wjcc.v12.i32.6517","DOIUrl":"10.12998/wjcc.v12.i32.6517","url":null,"abstract":"<p><p>The worldwide burden of tuberculosis (TB) has increased and it can involve virtually any organ of the body. Intestinal TB accounts for about 2% of the cases of TB worldwide. The ileocecal region is the most commonly affected site, and the foregut is rarely involved. The reported incidence is approximately 0.5%. Esophageal TB presents with dysphagia, weight loss, and hematemesis in rare cases. Gastroduodenal TB usually manifests with symptoms such as nausea, vomiting, weight loss, and sometimes with gastric outlet obstruction. Gastroscopy may reveal shallow ulcers in stomach and duodenal deformity when underlying TB is suspected, therefore histopathology plays pivotal role. On computed tomography, duodenal TB typically manifests as duodenal strictures predominantly, accompanied by extrinsic compression, and occasionally as intraluminal mass. But their diagnosis can easily be missed if proper biopsies are not taken and samples are not sent for GeneXpert testing, TB polymerase chain reaction investigation and histopathological analysis. Despite being in close proximity to the lungs, the esophagus and stomach are rare sites of TB. The reasons could be low gastric pH and acidity which does not let mycobacterium grow. But there are various case reports of TB involving the foregut. We have summarized the rare cases of foregut TB in different sections and highlighted the importance of esophagogastroduodenoscopy, histopathology and advanced techniques like endoscopic ultrasound in establishing the diagnosis.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6517-6525"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6551
Tae-Seok Chae, Da-Sol Kim, Gi-Wook Kim, Yu Hui Won, Myoung-Hwan Ko, Sung-Hee Park, Jeong-Hwan Seo
Background: Immunoglobulin G4-related disease (IgG4-RD) is a complex immune-mediated condition that causes fibrotic inflammation in several organs. A significant clinical feature of IgG4-RD is hypertrophic pachymeningitis, which manifests as inflammation of the dura mater in intracranial or spinal regions. Although IgG4-RD can affect multiple areas, the spine is a relatively rare site compared to the more frequent involvement of intracranial structures.
Case summary: A 70-year-old male presented to our hospital with a two-day history of fever, altered mental status, and generalized weakness. The initial brain magnetic resonance imaging (MRI) revealed multiple small infarcts across various cerebral regions. On the second day after admission, a physical examination revealed motor weakness in both lower extremities and diminished sensation in the right lower extremity. Electromyographic evaluation revealed findings consistent with acute motor sensory neuropathy. Despite initial management with intravenous immunoglobulin for presumed Guillain-Barré syndrome, the patient exhibited progressive worsening of motor deficits. On the 45th day of hospitalization, an enhanced MRI of the entire spine, focusing specifically on the thoracic 9 to lumbar 1 vertebral level, raised the suspicion of IgG4-related spinal pachymeningitis. Subsequently, the patient was administered oral prednisolone and participated in a comprehensive rehabilitation program that included gait training and lower extremity strengthening exercises.
Conclusion: IgG4-related spinal pachymeningitis, diagnosed on MRI, was treated with corticosteroids and a structured rehabilitation regimen, leading to significant improvement.
{"title":"Immunoglobulin G4-related spinal pachymeningitis: A case report.","authors":"Tae-Seok Chae, Da-Sol Kim, Gi-Wook Kim, Yu Hui Won, Myoung-Hwan Ko, Sung-Hee Park, Jeong-Hwan Seo","doi":"10.12998/wjcc.v12.i32.6551","DOIUrl":"10.12998/wjcc.v12.i32.6551","url":null,"abstract":"<p><strong>Background: </strong>Immunoglobulin G4-related disease (IgG4-RD) is a complex immune-mediated condition that causes fibrotic inflammation in several organs. A significant clinical feature of IgG4-RD is hypertrophic pachymeningitis, which manifests as inflammation of the dura mater in intracranial or spinal regions. Although IgG4-RD can affect multiple areas, the spine is a relatively rare site compared to the more frequent involvement of intracranial structures.</p><p><strong>Case summary: </strong>A 70-year-old male presented to our hospital with a two-day history of fever, altered mental status, and generalized weakness. The initial brain magnetic resonance imaging (MRI) revealed multiple small infarcts across various cerebral regions. On the second day after admission, a physical examination revealed motor weakness in both lower extremities and diminished sensation in the right lower extremity. Electromyographic evaluation revealed findings consistent with acute motor sensory neuropathy. Despite initial management with intravenous immunoglobulin for presumed Guillain-Barré syndrome, the patient exhibited progressive worsening of motor deficits. On the 45<sup>th</sup> day of hospitalization, an enhanced MRI of the entire spine, focusing specifically on the thoracic 9 to lumbar 1 vertebral level, raised the suspicion of IgG4-related spinal pachymeningitis. Subsequently, the patient was administered oral prednisolone and participated in a comprehensive rehabilitation program that included gait training and lower extremity strengthening exercises.</p><p><strong>Conclusion: </strong>IgG4-related spinal pachymeningitis, diagnosed on MRI, was treated with corticosteroids and a structured rehabilitation regimen, leading to significant improvement.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6551-6558"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.12998/wjcc.v12.i32.6575
Yan-Quan Liu
After perusing the paper by Kim et al, I discovered that this is an interesting manuscript and a successful study. Virtual reality (VR) is an emerging and promising technology employed in the domain of medical practice and medical education over the past decade. In the era of big data, VR is constantly progressing in the fields of medical education and clinical diagnosis and treatment. As a novel scientific and technological tool, VR not only overcomes multiple limitations of the traditional medical teaching mode but also reduces the reliance on personnel and equipment. VR can simulate the real clinical situation, stimulate the enthusiasm of young doctors and nurses for clinical study, and simultaneously safeguard and promote medical safety and doctor-patient harmony. Favorable outcomes have been attained in clinical teaching and diagnosis and treatment activities. While enhancing the training conditions of medical cosmetics and elevating the level of clinical practice and teaching, the risks resulting from improper clinical diagnosis and treatment have been circumvented. All of this is evident and comprehensible.
在阅读了 Kim 等人的论文后,我发现这是一篇有趣的手稿,也是一项成功的研究。虚拟现实(VR)是近十年来在医疗实践和医学教育领域应用的一项新兴技术,前景广阔。在大数据时代,虚拟现实技术在医学教育和临床诊疗领域不断进步。作为一种新颖的科技手段,VR 不仅克服了传统医学教学模式的多种局限性,还减少了对人员和设备的依赖。VR 可以模拟真实的临床场景,激发年轻医生和护士的临床学习热情,同时保障和促进医疗安全与医患和谐。在临床教学和诊疗活动中取得了良好的效果。在改善医学美容培训条件、提高临床实践教学水平的同时,规避了临床诊疗不当带来的风险。这些都是有目共睹的,也是可以理解的。
{"title":"Virtual reality: The bridge between medical education and clinical practice.","authors":"Yan-Quan Liu","doi":"10.12998/wjcc.v12.i32.6575","DOIUrl":"10.12998/wjcc.v12.i32.6575","url":null,"abstract":"<p><p>After perusing the paper by Kim <i>et al</i>, I discovered that this is an interesting manuscript and a successful study. Virtual reality (VR) is an emerging and promising technology employed in the domain of medical practice and medical education over the past decade. In the era of big data, VR is constantly progressing in the fields of medical education and clinical diagnosis and treatment. As a novel scientific and technological tool, VR not only overcomes multiple limitations of the traditional medical teaching mode but also reduces the reliance on personnel and equipment. VR can simulate the real clinical situation, stimulate the enthusiasm of young doctors and nurses for clinical study, and simultaneously safeguard and promote medical safety and doctor-patient harmony. Favorable outcomes have been attained in clinical teaching and diagnosis and treatment activities. While enhancing the training conditions of medical cosmetics and elevating the level of clinical practice and teaching, the risks resulting from improper clinical diagnosis and treatment have been circumvented. All of this is evident and comprehensible.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"12 32","pages":"6575-6579"},"PeriodicalIF":1.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}